ten Bosch John Roderick sold $321K of BLLN
ten Bosch John Roderick (SVP of Laboratory Operations) sold 2,834 shares of BillionToOne, Inc. (BLLN) at $113.17 ($0.32M total) across 2 trades on 2026-11-02 under a Rule 10b5-1 trading plan.
How this was made
The 30-second read
Why it matters
The disclosed sale adds a new data point for investors monitoring insider sentiment.
Market read
A modest insider sell that may prompt short‑term price pressure but is unlikely to move the stock significantly.
What to watch
Potential tax planning or diversification needs of the insider.
Background
SEC Form 4 filings provide the first public disclosure of insider transactions.
Ticker impact
Form 4 disclosed that SVP John Roderick sold 2,834 shares of BillionToOne for $320,724 on 2026-11-02.
likely pressure as the market prices in the insider sell
The sale is modest in size but indicates the insider is reducing exposure, which can be interpreted as a bearish signal.
Market effects
Minimal impact on the broader biotech sector.
No significant regional effect.
Limited to investors tracking insider activity.
Counterpoint
The sale may be unrelated to company fundamentals and could be a routine liquidity move.
Key entities
- companyBillionToOne, Inc.
Biotech company listed on US exchanges under ticker BLLN.
- personJohn Roderick
SVP of Laboratory Operations at BillionToOne, reporting the sale.

